Fig. 7From: Microfluidics for studying metastatic patterns of lung cancerSchematic diagram depicting the components of the microfluidic platform developed in the GEMNS project (EuroNanoMed II program) by the Nanotoxicology group, University of Bergen, Norway. In this setup, custom-made on-chip reservoirs are directly attached to the chip inlets and the fluid is withdrawn continuously through the outlets using pulsatile-free syringe pumps. The on-chip reservoirs are automatically refilled with homogeneous nanoparticle dispersions every 30 min using a programmable pressure pump. To ensure dispersion homogeneity, the liquid reservoir of the pressure pump is kept under agitation using a magnetic stirrer with a stirring bar that does not interact with nanoparticles. The microfluidic device consists of four independent microfluidic chambers, each with a microelectrode array to evaluate the cytotoxicity via a cell-substrate impedance sensing. Impedance measurements were performed sequentially using an electrode switch and a potentiostatBack to article page